Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

AstraZeneca : Japan to give 6 mln doses of vaccines to Taiwan, 5 SE Asia nations

06/24/2021 | 10:31pm EDT

TOKYO, June 25 (Reuters) - Japan said on Friday it would send 2 million additional doses of AstraZeneca Plc's COVID-19 vaccine to Taiwan and Vietnam and arrangements were being made to send 1 million doses each to Thailand, Malaysia, Indonesia and the Philippines.

The direct donations, which should help Japan to increase its diplomatic influence in Asia, come as wealthy nations are being pushed to provide more doses to the global vaccine sharing scheme COVAX to cover a 200-million dose shortfall.

While densely populated lower-income countries act as incubators for new and more dangerous strains of the coronavirus, some of the poorest countries have vaccinated fewer than 1% of their populations, according to estimates from Gavi, a global vaccine alliance that runs COVAX with the World Health Organization.

Japan has pledged $1 billion and 30 million doses to the COVAX facility and said this month its direct shipments to Asian neighbours are being made outside of COVAX to speed up delivery.

Japan donated 1.24 million doses to Taiwan and 1 million to Vietnam this month and plans to share an additional 1 million doses each with the two.

A Taipei-based official familiar with Japan's two vaccine donations said while the Japanese government has been subtle in its offers, mainly focusing on Taiwan's urgent medical need, there was a broader message.

The donations are actually an important move to echo the U.S. campaign of a free and open Indo-Pacific region to counter China's geopolitical clout in the region, the person said, speaking on condition of anonymity as they were not authorised to speak to the media.

Taiwan has accused China of blocking its access to foreign vaccines, which Beijing denies. The island, which China claims as its own territory, also received 2.5 million vaccine doses from the United States this month.

Japan is drawing on 120 million doses of the AstraZeneca vaccine it has reserved, as it has no immediate plans to use the shots at home amid lingering concern over international reports of blood clots.

Its foreign minister, Toshimitsu Motegi, said on Friday Japan would start to supply 11 million doses in total to regions including Southeast Asia, Southwest Asia and the Pacific islands through the COVAX from mid-July. (Reporting by Nobuhiro Kubo; Additional reporting by Ben Blanchard and Yimou Lee in Taipei; Writing by Elaine Lies; Editing by Jacqueline Wong and Christopher Cushing)

ę Reuters 2021
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC -0.29% 8244 Delayed Quote.12.89%
MSCI TAIWAN (STRD) -0.74% 690.203 Real-time Quote.15.72%
All news about ASTRAZENECA PLC
05:12aASTRAZENECA : H1 2021 results - Roadshow and conferences
04:49aASTRAZENECA : Secures US FDA Approval for Saphnelo in Moderate to Severe Systemi..
04:06aPFIZER : Malawi Ready to Store, Distribute Incoming Covid-19 Vaccine - Official
02:36aAstraZeneca's Saphnelo Approved in U.S. for Moderate-to-Severe SLE
02:27aASTRAZENECA : Lupus Therapy Wins US FDA Approval
02:12aASTRAZENECA : Saphnelo (anifrolumab) approved in the US for moderate to severe s..
08/01MARKET CHATTER : Pfizer, Moderna Raise COVID-19 Vaccine Prices in EU Supply Cont..
08/01CORONAVIRUS : Kenya has Received an Additional 410,000 Doses of AstraZeneca The ..
07/30ASTRAZENECA : H1 2021 results
07/30ASTRAZENECA : NHS - Presidential visit strengthens healthcare partnership with K..
More news
Financials (USD)
Sales 2021 35 065 M - -
Net income 2021 5 236 M - -
Net Debt 2021 26 467 M - -
P/E ratio 2021 30,4x
Yield 2021 2,45%
Capitalization 178 B 178 B -
EV / Sales 2021 5,83x
EV / Sales 2022 4,74x
Nbr of Employees 76 100
Free-Float 96,4%
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 29
Last Close Price 114,91 $
Average target price 133,77 $
Spread / Average Target 16,4%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Marc Pierre Jean Dunoyer Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas N. Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PLC12.89%178 110
JOHNSON & JOHNSON9.42%453 313
ROCHE HOLDING AG13.38%337 105
PFIZER, INC.16.30%239 637
NOVARTIS AG0.28%225 343